Cargando…
Synergy Between Two Chimeric Lysins to Kill Streptococcus pneumoniae
Phage lysins constitute a new generation of antimicrobials that are becoming a promising alternative and complementation to current antibiotic therapies, which are nowadays called into question by the increasing numbers of multiresistant bacteria. Streptococcus pneumoniae is a leading human pathogen...
Autores principales: | Vázquez, Roberto, García, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560164/ https://www.ncbi.nlm.nih.gov/pubmed/31231338 http://dx.doi.org/10.3389/fmicb.2019.01251 |
Ejemplares similares
-
Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen
por: Vázquez, Roberto, et al.
Publicado: (2017) -
The Alpha-Tocopherol Form of Vitamin E Boosts Elastase Activity of Human PMNs and Their Ability to Kill Streptococcus pneumoniae
por: Bou Ghanem, Elsa N., et al.
Publicado: (2017) -
PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related Species
por: Blázquez, Blas, et al.
Publicado: (2016) -
Effect of heat-killed Streptococcus thermophilus on type 2 diabetes rats
por: Gao, Xiangyang, et al.
Publicado: (2019) -
Systematic analysis of lysine malonylation in Streptococcus mutans
por: Li, Zhengyi, et al.
Publicado: (2022)